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Background: Access to care and treatment services for human immunodeficiency virus (HIV)/
acquired immunodeficiency syndrome (AIDS) are hampered by human resource constraints 
and knowledge gaps about antiretroviral therapy. Training people with HIV/AIDS (PWA) as 
educators on antiretroviral therapy may help in the expansion of antiretroviral therapy-related 
knowledge in Africa. The aim of this study was to assess the antiretroviral therapy-specific 
knowledge, beliefs, and attitudes of PWA as well as their proactive communication with com-
munity members and to explore their willingness to serve as support personnel.
Methods: Data were obtained from a large randomized trial of PWA. We analyzed qualita-
tive and quantitative data from 524 PWA aged 18 years and over who initiated home-based 
antiretroviral therapy in 2003. We assessed knowledge and communication of HIV prevention 
and treatment messages by PWA to communities using structured messages complemented with 
other knowledge questions and the willingness of PWA to serve as support persons. Descriptive 
bivariate associations and logistic regression statistical methods were performed. In addition, 
qualitative data analysis was used.
Results: The level of knowledge about antiretroviral therapy was high among all PWA on 
several technical attributes. Overall, 90% of PWA reported that they had been consulted by 
community members for informed opinions on antiretroviral therapy, 70% felt they were 
opinion leaders on aspects of antiretroviral therapy within the communities, and approximately 
70% were willing to be engaged as community support persons. Those who were classified as 
opinion leaders reported being approached more regularly by community members for expert 
advice about antiretroviral therapy compared with nonopinion leaders (odds ratio [OR] 11.7; 
95% confidence interval [CI] 7.3–18.6), and opinion leaders were significantly more informed 
on most technical attributes of antiretroviral therapy, such as “who qualifies for antiretroviral 
therapy based on CD4 count” (OR 1.6, 95% CI 1.1–2.0) and “the need to be evaluated for 
antiretroviral therapy” (OR 1.8, 95% CI 1.2–2.0).
Conclusion: Opinion leaders demonstrated correct knowledge and willingness to provide 
information on antiretroviral therapy care and treatment issues and were, in turn, consulted more 
frequently for antiretroviral therapy advice compared with nonopinion leaders. Training opinion 
leaders to work as community support personnel may increase knowledge about antiretroviral 
therapy in underserved communities.
Keywords: opinion leaders, antiretroviral therapy, knowledge, proactive communication, 
Uganda, human immunodeficiency virus
Introduction
The World Health Organization (WHO) has recently provided guidance on task-
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less developed regions. It is anticipated that some of the 
less demanding community-based tasks regarding human 
immunodeficiency virus (HIV)/acquired immunodeficiency 
syndrome (AIDS) management can be shifted to people with 
HIV/AIDS (PWA).1
HIV/AIDS rates in Uganda are still relatively high. 
In 2009, the prevalence rate was 6.4% in the age group 
15–49 years, translating into approximately 1.1 million 
people. HIV/AIDS in Uganda is categorized as a generalized 
epidemic. However, knowledge about antiretroviral therapy 
has remained low, at about 35% in this same age group. This 
inadequate knowledge possibly translates into low uptake 
of vital services, such as voluntary counseling, testing, and 
care and support services. Voluntary counseling and testing 
is an entry point into treatment and care services, but only 
about 12% Ugandans seek it out.2 As of 2010, approximately 
140,000 people in Uganda are receiving antiretroviral 
therapy.3 The low knowledge about antiretroviral therapy 
coupled with scarcity of the human resources necessary for 
promotion and sustenance of antiretroviral therapy programs 
are one of several reasons for low uptake of antiretroviral 
therapy programs. One strategy to address the low supply of 
human resources for HIV health services, especially in less 
developed countries, is the utilization of PWA as community 
support persons. This strategy is being proposed as a key to 
address general health worker shortages.1
The advent and scale-up of antiretroviral therapy has 
drastically reduced opportunistic infections and subsequent 
deaths.4 However, as antiretroviral therapy programs rapidly 
expand in resource-constrained settings, increasing access to 
information about antiretroviral therapy becomes imperative. 
Africa remains critically short of health workers, who are 
central in the provision of antiretroviral therapy programs.5–7 
Pilot projects in Africa have shown that the development of 
community-based antiretroviral therapy treatment support 
persons can lead to high treatment literacy, improve adher-
ence rates, and other multiple positive social outcomes.8,9 
Countries most affected by AIDS could appropriately develop 
a new cadre of health workers suitable to provide HIV-related 
services.10
The use of community support persons to disseminate 
information about HIV/AIDS prevention and related treat-
ment services could assist in improving antiretroviral therapy 
treatment literacy.11 A recent study in Uganda suggested that 
reassigning the work of monitoring and patient support to 
PWA could leave medical personnel free to handle clinical 
tasks.12 In line with the World Health Organization recom-
mendations on task shifting, PWA,1,13 who are regularly 
exposed to valuable HIV/AIDS and antiretroviral therapy 
information from clinic and project staff and have varied 
treatment experiences, could add value to community-based 
approaches to HIV prevention and treatment. Their infor-
mation and experiences could be shared with community 
members, both HIV-positive and HIV-negative, and might 
help to mitigate barriers to access and utilization of HIV/
AIDS services as well as lessening stigma and discrimina-
tion.7 PWA have been involved in the response against HIV/
AIDS since the first phases of the epidemic,5 and public health 
agencies recognize that their participation should continue 
to be actively encouraged.14,15
Despite this recognition, there has been little effort in 
assessing how PWA function in providing community sup-
port to antiretroviral therapy programs, particularly the type, 
frequency, and accuracy of information, and their attitudes 
and beliefs about antiretroviral therapy which they portray 
to community members. Our objective was to assess the 
specific knowledge, beliefs, and attitudes of PWA about 
antiretroviral therapy, as well as proactive communication 
about HIV/AIDS and antiretroviral therapy. We also set out 
to determine the proportion of PWA who were willing to be 
engaged as community support persons. A greater under-
standing of these factors could inform systematic efforts to 
utilize PWA effectively in prevention, treatment, care, and 
support programs in communities where human resources 
for health are in short supply.
Methods
We collected cross-sectional data between July 2005 and 
December 2005 as part of a large randomized control trial of 
1000 HIV-positive persons, aged 18 years and over, who initi-
ated home-based antiretroviral therapy between May 2003 
and November 2006. The trial was called the Home-Based 
AIDS Care project (HBAC), facilitated by a study clinic at 
Tororo District Hospital in Eastern Uganda. This study was 
approved by the Uganda National Council for Science and 
Technology, the Uganda Virus Science and Ethics Committee, 
and the Centers for Disease Control and Prevention.
Participant enrollment into the hBAc
All participants who were recruited into HBAC were 
seropositive for HIV . The HBAC was supported by the US 
President’s Emergency Plan for AIDS Relief, and managed 
jointly by the Centers for Disease Control and Prevention in 
collaboration with the Uganda Ministry of Health and local 
government districts of Tororo, Busia, and Mbale. Recruit-
ment into the trial started in May 2003 and continued through Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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November 2006. All the participants recruited into the HBAC 
were previously members of another HIV/AIDS organization 
called The AIDS Support Organization (TASO), which they 
had joined at varying times starting in the mid 1990s. Details 
of the HBAC trial are described elsewhere.16,17
sample selection
From the HBAC project, a quota sample of 524 participants 
was selected who had initiated antiretroviral therapy with a 
CD4 count of #250 cells/µL or with symptomatic AIDS, 
and lived within a 100 km radius of the clinic, aged 18 years 
or older, and had been receiving antiretroviral therapy and 
routine counseling for at least 18 months within the HBAC 
project.
Data collection
Research counselors were given training in specific methods 
for collecting sensitive information from PWA for a period 
of 1 month. Between July 2005 and December 2005, the 
counselors collected data from randomly selected eligible 
clients using a structured questionnaire that assessed HIV/
AIDS, antiretroviral therapy knowledge and misconceptions, 
and HIV-related communication and opinion leadership (an 
opinion leader was defined as a PWA who self-reported to 
be an expert on HIV/AIDS and antiretroviral therapy-related 
information within the community).
To assess knowledge and misconceptions about antiret-
roviral therapy for HIV/AIDS, five key thematic questions 
were asked using yes/no and multiple choice response 
options. To assess whether specific HIV/AIDS and anti-
retroviral therapy-related information were communicated 
by PWA, 22 typical messages were asked. We asked PWA 
what they typically told a community member about HIV/
AIDS or antiretroviral therapy. These questions were asked 
without prompting, and any mentioned response was marked 
off the list of 22. The 22 questions used were derived from 
conventional counseling messages in Uganda.18 Research 
counselors also collected demographic and screening infor-
mation at baseline and at 6-monthly follow-up intervals up 
to 18 months. The counselors had also provided routine 
voluntary counseling services on HIV/AIDS preventive 
and treatment-seeking behavior, positive living, and anti-
retroviral therapy adherence. PWA who self-reported to 
be experts on HIV/AIDS and antiretroviral therapy and 
community members consulted on HIV/AIDS/antiretroviral 
therapy-related information and advice were classified as 
opinion leaders and the rest were classified as nonopinion 
leaders. All quantitative data were double-entered using 
Epi-Info 2002 (Centers for Disease Control and Prevention, 
Atlanta, GA).
To complement quantitative data and triangulate infor-
mation, this study used some key qualitative data from the 
main HBAC study, which had a qualitative data compo-
nent. These data had been gathered routinely by behavioral 
research scientists. The data covered a range of issues related 
to antiretroviral therapy, including knowledge, attitudes, 
behavior, and practices of PWA. Qualitative data were 
entered in Nvivo2 (QSR International Pty Ltd, Victoria, 
Australia). A thematic codebook was developed, and spe-
cific content line segments were coded at nodes and later 
extracted at analysis.
Data analysis
For the quantitative portion of our study, we first used 
descriptive statistics for all sociodemographic variables 
to assess their distribution. Second, antiretroviral therapy 
knowledge, attitudes, beliefs, social status changes, sources 
of antiretroviral therapy information, changes in proactive 
communication by PWA about antiretroviral therapy, travel 
frequency, reported consultation of PWA by community 
members, opinion leadership, antiretroviral therapy mes-
sages communicated, and willingness to participate as 
community support persons were tabulated. Third, we 
classified PWA as opinion leaders or nonopinion leaders, 
and Chi-square tests were conducted along with unadjusted 
odds ratios (OR) and confidence intervals (CI) to assess dif-
ferences in levels of communication and knowledge about 
antiretroviral therapy between opinion leaders or nonopinion 
leaders. We stratified by gender, marital status, education, 
reported consultation of PWA by community members, 
reported social status changes, and travel frequency of the 
PWA to assess for any significant differences. All quantita-
tive analyses were conducted using SAS version 9.1 (SAS 
Institute, Cary, NC).
For qualitative data, we aimed to seek a more detailed 
understanding of the participants’ beliefs and attitudes 
about HIV and antiretroviral therapy, as well as how PWA 
have been sharing their treatment experiences within the 
communities. Some of the specific content areas identified 
were how PWA managed their disease condition, including 
overcoming stigma, community attitudes towards PWA, 
current social status and roles, and indepth knowledge of 
antiretroviral therapy. We also explored the willingness of 
PWA to participate in the proposed projects as commu-
nity educators (Table 2). Qualitative data were analyzed 
in Nvivo2.Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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Results
Participant characteristics
A total of 987 adult clients (74% female) initiated 
  antiretroviral therapy from May 2003 through December 
2006 in the main randomized trial, and 524 (71% female) 
who had completed 18 months of follow-up were enrolled 
in this substudy. Of the 524 PWA, 371 (71%) were females 
and 210 (40%) had completed primary education, with sig-
nificant differences between the two gender groups (22% 
female versus 38% male, P , 0.01). Overall, 232 (45%) 
were married and there were more married males compared 
with females (80% versus 30%, respectively, OR 9, 95%, 
CI 5.7–14.3, P , 0.01.). The median age at enrollment 
was 38 years (interquartile range 31–42 years) for females 
and 41 years (interquartile range 34–47 years) for males. As 
shown in Table 1, most PWA were Catholics 221 (45%) or 
Protestants (35%).
social status change among PWA since 
initiation of antiretroviral therapy
After 18 months on antiretroviral therapy, all participants 
reported improvements in social status that included 
increased social interactions, more prominent roles in 
the community, influence of PWA in the community, 
and/or positive community views of PWA. Social status 
increased greatly among both males (85%) and females 
(78%), but the gender difference was not statistically dif-
ferent (P = 0.07). However, opinion leaders reported better 
improvement than nonopinion leaders (OR 5.0, 95% CI 
3.3–8.0, P , 0.001)
sources of information about 
antiretroviral therapy
The main sources of information about antiretroviral therapy 
for all PWA were HBAC study counselors (81%), field 
officers (65%), and radio (43%). About 19% said that they 
heard about antiretroviral therapy from fellow PWA who 
were registered members with the HBAC project.
Level of antiretroviral therapy knowledge
Most PWA exhibited high levels of knowledge and 
understanding of antiretroviral therapy issues (Table 2). 
Responses to the two questions, “What do antiretrovirals 
do?” and “When should one start antiretrovirals?” were 
answered correctly by the majority of PWA. For instance, 
443 (85%) spontaneously mentioned that antiretroviral 
therapy improves health and immune system functioning. 
Similarly, a relatively large proportion of PWA, ie, 386 
(74%) clearly expressed that an HIV-positive person needs 
to start antiretroviral therapy when the CD4 count is less than 
#250 cells/µL. Additionally, 241 (46%) replied that anti-
retroviral therapy prolongs the life of PWA and 217 (41%) 
said antiretroviral therapy reduces opportunistic infections. 
Incorrect information about antiretroviral therapy was men-
tioned by a small proportion, such as those who answered 
positively that antiretroviral therapy kills HIV (17 [3%]) 
and cures AIDS (23 [4%]). The median number of correct 
answers about antiretroviral therapy was three, and at least 
31% mentioned more than four answers correctly.
The qualitative data corroborated the evidence that 
PWA are knowledgeable about antiretroviral therapy and 
they shared extensive stories about attributes related to 
drug functions. For instance, they mentioned drugs such as 
Septrin® (cotrimoxazole, a drug for opportunistic infections 
in all PWA, regardless of CD4 cell count/µL).19,20 Similarly, 
Table 1 sociodemographic and background attributes of PWA 
after 18 months on antiretroviral therapy, home-Based AiDs 
care project, 2005
Background variables All n (%) Female n (%) Male n (%)
524 (100) 373 (%) 151 (%)
none 128 (25) 113 (31) 15 (10)
Primary 248 (48) 171 (47) 77 (52)
Postprimary 137 (27) 82 (22) 55 (38)
catholic 221 (42) 155 (42) 66 (44)
Moslem 42 (8) 25 (7) 17 (11)
Pentecostal 80 (15) 57 (15) 21 (14)
Protestant 181 (35) 134 (36) 47 (31)
Marital status
Married 232 (45) 113 (30) 119 (80)
not married 287 (55) 257 (70) 30 (20)
18–30 54 (10) 45 (12) 9 (6)
31–40 216 (41) 162 (43) 54 (36)
41–50 188 (36) 130 (35) 58 (38)
50+ 66 (13) 36 (10) 30 (20)
At least once per week 159 (30) 94 (25) 65 (43)
Once a month 10 (21) 74 (20) 36 (24)
rarely 254 (49) 204 (55) 50 (33)
improved 413 (81) 287 (78) 126 (85)
stayed same 98 (19) 83 (22) 23 (15)
Daily/several times  
per week
111 (21) 65 (18) 46 (31)
Once per week 69 (13) 49 (13) 20 (13)
Occasionally 295 (57) 218 (59) 77 (51)
never 45 (9) 38 (10) 7 (5)
Farming 203 (39) 141 (38) 62 (44)
Wages 77 (16) 50 (14) 27 (19)
Dependent 91 (18) 80 (22) 11 (8)
Trade 136 (26) 95 (26) 41 (29)
Abbreviations: n, number; AiDs, acquired immunodeficiency syndrome; PWA, 
people with human immunodeficiency virus/AiDs.Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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they mentioned clean water and other antiretroviral agents. 
Clean water use is mentioned here because previous deaths 
of most PWA in this area were associated with dirty water 
that resulted in diarrhea-related diseases.21
Beliefs about antiretroviral therapy
The participants were asked whether they felt that their 
feelings and thoughts had changed after starting anti-
retroviral therapy. The most striking beliefs were those 
related to hopes of living longer (78%), feeling of being 
healthy with less illness (62%), and reduction in worries 
and fear (42%).
The qualitative data revealed that PWA perceived com-
munity members as having some false beliefs about the health 
of HIV-positive individuals and, in some cases, the role of 
antiretroviral therapy in particular. For instance, some PWA 
revealed that when their health improved, such as gaining 
of weight and reduction in opportunistic infections,21,22 com-
munity members started wondering whether these PWA 
actually had AIDS.
Type and frequency of information about 
antiretroviral therapy
Generally, the most frequently provided message was about 
who qualifies for antiretroviral therapy followed by the need 
to register with an AIDS service organization and the role of 
antiretroviral therapy with respect to prolonging the life of 
PWA. These results are summarized in Table 3.
Overall, 408 (78%) PWA reported having provided 
information to community members since enrolling in the 
HBAC. However, the frequency with which they commu-
nicated about HIV/antiretroviral therapy varied, with 111 
(21%) responding that they provided information every 
day, 69 (13%) responding once a week, the majority saying 
occasionally (95 [56%]), and 45 (9%) saying never. There 
was also an increase in the proportion of individuals who said 
they ever communicated about HIV/AIDS, testing, serostatus, 
Table 2 Percentage of responses by people with hiV/AiDs to two 
antiretroviral knowledge questions after 18 months on antiretroviral 
therapy, home-Based AiDs care project, 2005 (n = 524)*
Specific knowledge about  
antiretroviral therapy
Responses (%)
Answers to question: What do ArV drugs do?
Kills hiV 3
increases sickness 1
cures AiDs 4
improves health/strength/immune system 85
slows the progression of hiV 44
reduces opportunistic infections 41
increases cD4 count 38
Decreases the level of virus in the body 42
Prolongs life of PWA 46
Kills people 1
Don’t know 1
causes bad side effects 6
Answers to question: When should a person with hiV/AiDs start ArV?
When they are physically sick 11
As soon as they test positive 1
When they are too weak to continue their  
daily activities
12
When their cD4 count is , 250 74
Don’t know 1
not all hiV-positive people need ArV 78
After improvement on antiretroviral therapy  
one should continue
93
Note: *The responses were spontaneous.
Abbreviations:  ARV,  antiretroviral  therapy;  AIDS,  acquired  immunodeficiency 
syndrome; HIV, human immunodeficiency virus; PWA, people with HIV/AIDS.
Table  3  Antiretroviral  therapy  messages  communicated  to 
community  members  by  people  with  hiV/AiDs,  comparing 
opinion leaders with nonopinion leaders
ARV messages  
communicated
OPLs  
n = 370  
n (%)
Non-OPLs  
n = 152  
n (%)
P value OR
ArV is for those  
with cD4 , 250
192 (51) 61 (40) 0.019 1.6 (1.1–2.4)
You need an hiV  
test before ArV
189 (51) 54 (36) 0.002 1.9 (1.3–2.8)
ArV prolongs  
your life
42 (11) 6 (4) 0.679 0.9 (0.6–1.3)
need to register  
with an AiDs  
service facility  
to access ArV
194 (52) 55 (36) 0.001 1.9 (1.3–2.9)
You need to be  
evaluated for ArV
144 (39) 40 (26) 0.008 1.8 (1.2–2.7)
Adherence to ArV  
is important
82 (22) 31 (20) 0.743 1.1 (0.7–1.8)
not everyone  
with hiV needs  
antiretroviral  
therapy
68 (18) 19 (12) 0.135 1.6 (0.9–2.7)
ArV should not be  
shared with others
64 (17) 20 (13) 0.299 1.4 (0.8–2.4)
ArV does not cure 
hiV/AiDs
75 (20) 42 (28) 0.086 0.7 (0.4–1.0)
While on ArV, you  
remain infectious  
if you don’t use  
condoms
53 (14) 13 (9) 0.097 1.8 (0.9–3.4)
Once on ArV, you  
take it for life
58 (16) 31 (20) 0.240 0.7 (0.4–1.2)
Abbreviations:  ARV,  antiretroviral  therapy;  AIDS,  acquired  immunodeficiency 
syndrome;  HIV,  human  immunodeficiency  virus;  PWA,  people  with  HIV/AIDS; 
OPLs, opinion leaders; non-OPLs, nonopinion leaders; Or, odds ratio.Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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or antiretroviral therapy from the time they joined HBAC, 
from 267 (51%) to 408 (78%). Results show that females 
reported that they provided antiretroviral therapy information 
on a daily basis less frequently than males (18% of females 
versus 31% of males, P , 0.001).
The qualitative analysis revealed some critical issues 
which the community members usually discussed with 
respect to PWA. They included lack of fear of HIV , men’s 
desire for children even when they are sick, and aspects of 
prevention of mother to child transmission of HIV . Other 
community members simply believe that when PWA produce 
children, they are actually spreading the virus.
self-reported opinion leadership
Overall, there were more opinion leaders (370 [71%]), ie, 
those who self-reported to be leaders in aspects of HIV/
AIDS and antiretroviral therapy, than nonopinion leaders. 
Significant differences were observed by education. Close 
to 30% of the opinion leaders had postprimary education 
compared with 17% of the nonopinion leaders (P , 0.001). 
There was no significant difference between the groups with 
respect to marital status, gender, and religion. The opinion 
leaders were consulted by the community members for advice 
more often than the nonopinion leaders (72% versus 18%, 
OR 11.7, CI 7.3–18.6).
community member consultations  
with PWA about antiretroviral therapy
We asked all PWA whether community members consulted 
them for antiretroviral therapy-specific advice. We used this 
as another variable to assess if PWA are opinion leaders in 
their community. We compared the response about consulta-
tion by the community and previously self-reported opinion 
leadership. Among those who self-reported to be opinion 
leaders, 71% reported being consulted by the community 
whereas among those who self-reported to be nonopinion 
leaders, only 18% were consulted.
Discussion
We found a relatively high specific knowledge level about 
HIV/AIDS and antiretroviral therapy and PWA engage-
ment in proactive information-sharing. There is evidence of 
informal networks emerging where community members 
consult PWA for information and advice in general about 
HIV/AIDS and in particular about antiretroviral therapy. In 
antiretroviral therapy program management, accurate knowl-
edge and timely information that facilitates antiretroviral 
therapy uptake is crucial.24–26 Shared information between 
PWA and community members could positively influence 
HIV-positive community members to seek treatment and care 
services which will in turn lead to uptake of antiretroviral 
therapy. Likewise, community members who have never 
taken an HIV test could be influenced to seek one and benefit 
from prevention counseling or join AIDS service facilities if 
they are found to be HIV-positive. We maintain that formal 
arrangements to engage PWA as community-based support 
personnel should be undertaken urgently. This is based on 
the findings that the PWA are quite knowledgeable, more 
familiar with community members, and are already executing 
these information-sharing tasks in an informal manner.
The PWA reported positive beliefs, indicating self-efficacy, 
a wish to live longer, positive changes in social status, and a 
willingness to speak out and influence others. This could mean 
that PWA are gradually overcoming the stigma that in the 
past was a major obstacle to HIV/AIDS services in Uganda.27 
The stigma has been so strong that, in the initial phases of 
the HBAC program, community members tried to dissociate 
themselves from homes which were being visited by the pro-
gram motorcycles during follow-up and drug delivery. Because 
stigma is one of the biggest obstacles to voluntary counseling, 
testing uptake, and antiretroviral therapy initiation,28  PWA 
could play a more important role in influencing community 
members given their experience, level of familiarity, and 
success stories. Similarly, because the stigma is decreasing, 
PWA will hopefully meet limited resistance from community 
members and would be able to execute their assigned tasks.
There are many emotional and psychological challenges 
surrounding proper communication about HIV/AIDS due to 
its life-threatening nature.29 PWA taking antiretroviral therapy 
could use their treatment experiences to help other com-
munity members overcome obstacles to care and treatment. 
These could include helping newly diagnosed community 
members disclose their status to partners and children, guid-
ing them to appropriate treatment centers, counseling them 
to adhere to antiretroviral therapy, and providing them with 
an enabling environment to cope with the disease.
In recent times, the limitations of clinic-based services 
have become more apparent and there is a growing realiza-
tion and acknowledgment of the appropriateness (acces-
siblity, linkages, coverage, and acceptability) of involving 
community-based health workers to meet the health needs of 
populations, especially in resource-poor regions.30 We sug-
gest formal involvement of PWA to serve as links between 
antiretroviral therapy facilities and communities. Both in this 
analysis and in the literature there is strong evidence that 
PWA are willing to undertake these tasks.31Patient Preference and Adherence 2011:5 submit your manuscript | www.dovepress.com
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Although opinion leaders and nonopinion leaders in this 
study were quite different in several demographic charac-
teristics, they differed slightly in only four aspects of com-
municating antiretroviral therapy messages, and both groups 
reported being approached by community members for 
informed opinion on matters of antiretroviral therapy. How-
ever, the self-reported opinion leaders were more frequently 
approached than the nonopinion leaders. In the four techni-
cal aspects where both groups differed, the opinion leaders 
were more accurate on specific messages than nonopinion 
leaders. This suggests that antiretroviral therapy programs 
should formally target those PWA who self-report to be 
opinion leaders. Upon identifying these individuals, regular 
support (technical and support supervision) may be planned 
and executed to reinforce their subject content.
Although our study undertook critical methodological steps 
in the design, implementation, and analysis stages, it was not 
able to circumvent completely the usual limitations related to 
self-reported data. In this study, all the responses were self-
reported. Self-reporting has been shown to lead to social desir-
ability bias.32 To determine adequately if community members 
consult PWA, rather than relying solely on self-reported infor-
mation from PWA, a community-based study using qualitative 
and quantitative methods involving only HIV-negative persons 
would have possibly confirmed the frequency and level of 
consultation with PWA by community members.
We minimized knowledge-related reporting bias by 
asking several core antiretroviral therapy questions relating 
to knowledge, beliefs, attitudes, willing to participate, and 
opinion leadership using nonprompting techniques, ie, asking 
for answers spontaneously. We also recruited experienced 
research counselors to collect detailed sensitive information. 
Additionally, a qualitative methodology was also adopted 
in order to triangulate the collected information. Neither 
the quantitative nor the qualitative findings varied greatly. 
Given that most of the PWA in this study had lived with 
the disease for long periods, ie, a minimum of nine years, 
we are confident that their knowledge about antiretroviral 
therapy had also progressively improved due to exposure to 
the educational messages received.
Moreover, the study population may not be representative, 
given that all the PWA had engaged in HIV-related programs 
for many years, because they were initially members of 
TASO, an organization which has operated for nearly two 
decades. Their previous participation in TASO might have 
significantly improved their antiretroviral therapy knowledge, 
and changed their attitudes as well as beliefs. Therefore, gen-
eralization of these results to other rural settings may require 
some modifications for suitability and context. However, in 
rural communities where TASO and other related HIV/AIDS 
service organization operate and offer similar services, the 
transferability of these findings would be appropriate.
Lastly, this analysis was not able to determine factors that 
caused PWA to have particular knowledge of antiretroviral 
therapy, beliefs, attitudes, or willingness to serve as community 
support persons due to the limitations of cross-sectional data. 
In other words, although the main study was a controlled trial, 
this particular study used cross-sectional data. A combination 
of many factors, notwithstanding their previous membership in 
TASO, followed by enrollment in HBAC, might have played 
a significant role in shaping their current readiness to become 
community educators. We also acknowledge that the data are 
relatively old, given the time period during which the project 
was implemented (2003–2006). However, this important area 
of HIV research has not been sufficiently studied in Uganda.
Conclusion
Despite these limitations, our findings are timely in that 
they provide comprehensive information to PWA regarding 
current antiretroviral therapy knowledge, proactive commu-
nication, and consultation with community members about 
HIV and antiretroviral therapy. In addition, they reveal the 
willingness of PWA to serve as community support personnel 
in current efforts to expand antiretroviral therapy programs in 
resource-poor countries. Appropriate integration of PWA in 
antiretroviral therapy programs in rural Africa, particularly 
Uganda, would serve as a beneficial strategy to improve HIV 
treatment, health-seeking behaviors, uptake of antiretroviral 
therapy services, and provide strategies for responding to the 
critical issues of human health care resources in the struggle 
against HIV/AIDS.
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